liraglutide vs semaglutide vs. liraglutide: Head-to-head study reveals a diabetes risk difference Liraglutide vs Semaglutide: Best for

We specifically discuss the structure and pharmacological properties of TT-OAD2, LY3502970, and PF-06882961, and envision an era where more patients could benefit from oral GLP-1 receptor agonist therapy

Additionally, GLP-1RAs or dual GIP/GLP-1 receptor agonists have been combined with other nutrient-based hormone (e.g., glucagon and amylin) receptor agonists (7782), a detailed discussion of which is beyond the scope of this review

Wang Z et al

Given the stable HRs across the spectrum of frailty, these differences in number needed to treat between frail and non-frail people are primarily driven by the higher number of events among frail patients, which highlights the greater vulnerability of this population. Lower CV risk with SGLT2 inhibitors vs

A 2024 study reviewed data from the national databases to understand the effects of diet and exercise on constipation